Down syndrome: Bridging Genes and Neural Pathways
Down syndrome: Bridging Genes and Neural Pathways
批准号:
7177523
负责人:
JULIE RUTH KORENBERG
金额:
$32.18万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-12 至 2008-12-31
关键词:
AffectAggressive behaviorAgingAlzheimer&aposs DiseaseAmygdaloid structureAneuploidyAntibodiesArchitectureAttentionBasal GangliaBehaviorBehavioralBrainBreedingCalciumCalmodulinCell LineCell modelCellsCellular biologyCerebellumCerebral cortexCholinergic AgentsChromosomes, Human, Pair 21CognitionCollaborationsConsultDataDendritesDendritic SpinesDevelopmentDown SyndromeEstrogensFemaleFundingGene ExpressionGenesGoalsGolgi ApparatusHabenulaHippocampal FormationHippocampus (Brain)HumanImmunohistochemistryKnockout MiceLateralLeadLearningLimbic SystemLiteratureLocalizedMacacaMeasuresMedialMediatingMedicineMemoryMental RetardationModelingMonkeysMusNeocortexNerve DegenerationNeural PathwaysNeurobiologyNeuronsNumbersPathway interactionsPatternPersonsPhenotypePhosphorylationPopulationPrefrontal CortexProsencephalonProtein OverexpressionProteinsPurkinje CellsQuantitative Reverse Transcriptase PCRRegulationReportingResearchResourcesRoleSeriesSignal PathwaySilverSocial BehaviorStaining methodStainsStructureStructure of subthalamic nucleusStudy SectionSystemTechniquesTestingTransgenesTransgenic MiceTransgenic OrganismsTreesTrisomyUniversitiesWorkbasebehavior observationbehavior testbrain behaviorcholinergicdentate gyrusdesignflyhuman Huntingtin proteinhuman diseaseinsightmalemouse modelneuronal cell bodyneuroprotectionnonhuman primatenovelnovel strategiespromoterprotein expressionputamenrelating to nervous systemresearch studysuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A. Specific Aims
The ultimate goal of our research is to elucidate the pathways underlying the altered neurobiology of
Down syndrome, focusing on neocortex and hippocampus. The past decade has focused on sequencing
chromosome 21, evaluating gene expression in cell lines and trisomic mouse models, identifying signaling
pathways involving chromosome 21 genes, and looking at the effects of segmental trisomy in mouse, on
cellular, neuroanatomic and behavioral phenotypes. The results of these studies may lead to new
approaches to ameliorate the deleterious effects of these genes on development and cognition in DS.
Systems Medicine:
Our work provides insights that support a fundamental change in the approach to mental retardation,
from orientation on single components to the use of a broader, neural systems based approach to identify
common pathways that may underly a spectrum of MR in humans. Beginning with humans with partial
trisomy for 21, we identified regions and then single genes likely involved in MR in DS and then generated
single gene mouse models, relating findings to humans with aneuploidy for 21. In the current year, we have
identified expression patterns and abnormalities in the brains of these mice (and in our other chromosome
21 models), at the level of brain structure, the dendritic tree, dendritic spine, behavior and cell biology
(additional model), and have begun to generate fly models of the same subset of DS genes, and to
investigate their gene expression in non-human primates. Combining the data from DS and mouse models
suggests that disturbances of a smaller number of common developmental pathways may underly a broader
spectrum of MR and focus models in which to test these. It is important to note that the recent report of a
mouse model generated with sequences originating from human (not mouse) chromosome 21 (Fisher and
"^Progress has been made in all aims, with exciting accomplishments including the knock-out mouse
for dscam, the establishment of fly models for DS/ chromosome 21 genes, the beautiful Golgi Staining
for dendrites, spines and neuronal systems altered in the Pcp4/ PEP19 transgenic, the identification of
meso-limbic system expression of Pcp4/PEP19Jn mouse, and finally, emerging from this findings
produced by this proposal, but beyond the funded scope, expression in limbic system of Macaque
fasicularis (monkey), and preliminary evidence in DS for abnormal specific neuronal populations in
human prefrontal cortex. Accomplishments and plans are listed under each aim.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Molecular and cellular characterization of the Down syndrome critical region protein 2.
唐氏综合症关键区蛋白 2 的分子和细胞特征。
DOI:
10.1016/j.bbrc.2004.09.226
发表时间:
2005
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Vesa,Jouni, Brown,Ying, Greenfield,Danielle, Korenberg,JulieR]
通讯作者:
Korenberg,JulieR
DOI:
10.1523/jneurosci.3624-08.2009
发表时间:
2009-03-04
期刊:
JOURNAL OF NEUROSCIENCE
影响因子:
5.3
作者:
[Amano, Kenji, Fujii, Morimitsu, Yamakawa, Kazuhiro]
通讯作者:
Yamakawa, Kazuhiro
MOLECULAR GENETIC BASIS OF WILLIAM'S SYNDROME
-
批准号:8174457
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2009
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
A Computational Framework for Mapping Long Range Genetic Circuits
-
批准号:7845097
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2009
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
A Computational Framework for Mapping Long Range Genetic Circuits
-
批准号:7938599
-
项目类别:
-
资助金额:$49.91万
-
财政年份:2009
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
MOLECULAR GENETIC BASIS OF WILLIAM'S SYNDROME
-
批准号:7952198
-
项目类别:
-
资助金额:$1.21万
-
财政年份:2008
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
Williams Syndrome: The Molecular Genetic Characterization
-
批准号:7003873
-
项目类别:
-
资助金额:$24.42万
-
财政年份:2004
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
Down syndrome: Bridging Genes and Neural Pathways
-
批准号:7018513
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2003
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
Down syndrome: Bridging Genes and Neural Pathways
-
批准号:6832836
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2003
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
Down syndrome: Bridging Genes and Neural Pathways
-
批准号:6700035
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2003
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
Down syndrome: Bridging Genes and Neural Pathways
-
批准号:6760096
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2003
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
BRIDGING GENES AND HEART DISEASE IN DOWNS SYNDROME
-
批准号:6565101
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2002
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
BRIDGING GENES AND HEART DISEASE IN DOWNS SYNDROME
-
批准号:6451098
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2001
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
WILLIAMS SYNDROME--MOLECULAR GENETIC CHARACTERIZATION
-
批准号:6395957
-
项目类别:
-
资助金额:$14.51万
-
财政年份:2000
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
BRIDGING GENES AND HEART DISEASE IN DOWNS SYNDROME
-
批准号:6302532
-
项目类别:
-
资助金额:$17.74万
-
财政年份:2000
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
TUMOR SUPPRESSOR GENES IN HUMAN THYROID NEOPLASMS
-
批准号:6416412
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2000
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
MOLECULAR BASIS FOR DYSLEXIA IN KLINEFELTERS SYNDROME
-
批准号:6416419
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2000
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
DOWN SYNDROME NEUROGENESIS AND COGNITION--GENES AND FUNCTION
-
批准号:6301889
-
项目类别:
-
资助金额:$17.74万
-
财政年份:2000
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
MOLECULAR GENETIC BASIS OF WILLIAMS SYNDROME
-
批准号:6416420
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2000
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
MOLECULAR BASIS FOR DYSLEXIA IN KLINEFELTERS SYNDROME
-
批准号:6306706
-
项目类别:
-
资助金额:$0.1万
-
财政年份:1999
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
DOWN SYNDROME NEUROGENESIS AND COGNITION--GENES AND FUNCTION
-
批准号:6108376
-
项目类别:
-
资助金额:$17.74万
-
财政年份:1999
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
TUMOR SUPPRESSOR GENES IN HUMAN THYROID NEOPLASMS
-
批准号:6306699
-
项目类别:
-
资助金额:$0.1万
-
财政年份:1999
-
负责人:JULIE RUTH KORENBERG
-
依托单位:
海外基金